The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2007, 179: 195-200.
Copyright © 2007 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moran, S. T.
Right arrow Articles by Pillai, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moran, S. T.
Right arrow Articles by Pillai, S.

Synergism between NF-{kappa}B1/p50 and Notch2 during the Development of Marginal Zone B Lymphocytes1

Stewart T. Moran2, Annaiah Cariappa2, Haoyuan Liu, Beth Muir, Dennis Sgroi, Cristian Boboila and Shiv Pillai3

Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02129

NF-{kappa}B1 and Notch2 are both required for the development of marginal zone (MZ) B cells. Analysis of B lymphocyte development in mice that are doubly heterozygous at the Notch2 and NF-{kappa}B1 loci revealed synergism between Notch2 and NF-{kappa}B1 during MZ B cell development. Two known transcriptional targets of the Notch pathway, Hes-5 and Deltex-1, were found to be preferentially expressed in MZ B cells and regulated by NF-{kappa}B1. These studies provide in vivo evidence for a genetic interaction between the Notch and NF-{kappa}B pathways.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by National Institutes of Health Grants AI 064930 and CA102793.

2 S.T.M. and A.C. were equal contributors.

3 Address correspondence and reprint requests to Dr. Shiv Pillai, Massachusetts General Hospital Cancer Center, Building 149, 13th Street, Charlestown, MA 02129. E-mail address: pillai{at}helix.mgh.harvard.edu

4 Abbreviations used in this paper: IKK, I{kappa}B kinase; FO, follicular; MZ, marginal zone; Btk, Bruton’s tyrosine kinase; BAFF, B cell-activating factor of the TNF family; BAFF-R, BAFF receptor; FO-I, FO type I; FO-II, FO type II; MZP, MZ precursor; NF, newly formed.




This article has been cited by other articles:


Home page
J. Immunol.Home page
A. Cariappa, C. Boboila, S. T. Moran, H. Liu, H. N. Shi, and S. Pillai
The Recirculating B Cell Pool Contains Two Functionally Distinct, Long-Lived, Posttransitional, Follicular B Cell Populations
J. Immunol., August 15, 2007; 179(4): 2270 - 2281.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.